Respiratory

Asthma is a chronic inflammatory disease that causes the airways in the lungs to narrow and swell. Symptoms include wheezing, breathlessness, chest tightness, cough and Asthma attacks (exacerbations).

At Valeo Pharma we are launching novel asthma medications so that as Canadians We Can Do Better.

%

Of Asthma Patients were uncontrolled based on CTS Guidelines 2

%

Of Patients had poorly controlled asthma based on CTS Guidelines

 
Asthma Product

Enerzair® breezhaler®

Asthma is a chronic inflammatory disease that causes the airways in the lungs to narrow and swell. Symptoms include wheezing, breathlessness, chest tightness, cough and Asthma attacks (exacerbations).

Learn More

Value Proposition

TRIPLE THERAPY
In Asthma1
LABA/LAMA/ICS

One Inhalation Once a day

Indacaterol (as acetate)
Glycopyrronium (as bromide)
Mometasone Furoate

TOGETHER IN BREEZHALER ® Device

Available Strengths
150 mcg/50 mcg/160 mcg.
DIN 02501244

Asthma Product

Atectura® breezhaler®

Next generation dual therapy LABA/ICS.
Partner with Novartis Pharma Canada

Learn More

Value Proposition

Next Generation Dual THERAPY
in asthma1 LABA/ICS

One Inhalation Once a day

Indacaterol (as acetate)
Mometasone Furoate
TOGETHER IN BREEZHALER ® Device

Available Strengths
150 mcg/80 mcg. DIN 02498685
150 mcg/160 mcg. DIN 02498707
150 mcg/320 mcg. DIN 02498693

Select a Therapeutic Area

Respiratory

Specialty Products

Neurology

Oncology